Against a variety of headwinds, Intuitive Surgical placed 322 new da Vinci systems worldwide in the third quarter and saw its procedure volume grow 19% compared to the third quarter of 2022, building on momentum from the first half of 2023.
Intuitive Surgical Stock Remains Suppressed, Despite Procedure Growth
Anti-corruption campaigns in China, a shift towards leasing systems and the ever-problematic presence of GLP-1 inhibitors has led analysts, journalists and commentators to voice concerns about the robotic surgery giant.
More from Business
More from Medtech Insight
• By
The General Services Administration’s updated list of “assets identified for accelerated disposition” does not include any buildings at the agency’s headquarters in White Oak, MD after its original list of “non-core” government properties for disposal had more than half the buildings on campus.
• By
Exer Labs Inc.’s website marketed its AI-based Exer Scan app to “screen and treat Parkinson’s, TB, Cerebral Palsy and more.” But those claims went well beyond what was allowed under the product’s 510(k) clearance, US regulators say.
• By
Early diagnosis can be “detrimental” to patients, Suzanne O'Sullivan, neurologist and author of “The Age of Diagnosis,” argued at the Wired Health conference on 18 March. "You save one life from screening 2,000 women for breast cancer, but you also treat 10 women unnecessarily," she said.